A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo

Clinical trial NCT04492436 · WITHDRAWN

Trial details

NCT number: NCT04492436
Sponsor: Veloxis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy

Start date: 2021-10-01
Primary completion: 2023-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.